Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis

BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI) are associated with high morbidity and mortality. More in vitro, in vivo, and clinical data suggest that vancomycin (VAN) or daptomycin (DAP) combination therapy with β-lactams (BL) improves outcomes of MRSA...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Infect Dis Ther
Autores principales: Alosaimy, Sara, Sabagha, Noor L., Lagnf, Abdalhamid M., Zasowski, Evan J., Morrisette, Taylor, Jorgensen, Sarah C. J., Trinh, Trang D., Mynatt, Ryan P., Rybak, Michael J.
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7237588/
https://ncbi.nlm.nih.gov/pubmed/32248513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-020-00292-8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares